Angel Tax Is Gone: What Indian Founders and Angel Investors Still Need to Know

Angel Tax Is Gone. The Paperwork, Valuation and Founder Mistakes Are Not.

I have spent enough time with founders and chartered accountants to know that a tax announcement is rarely the end of a problem. It is usually the beginning of a new round of interpretation.

So let me answer the obvious question plainly: yes, angel tax has been abolished in India. The Union Budget announced the removal of Section 56(2)(viib) of the Income-tax Act for all classes of investors. This removes the tax on the difference between the price at which a startup issues shares and the fair market value assessed by the tax authorities.

That is excellent news. I have seen this provision create anxiety, delay fundraising, and force founders to defend an early-stage valuation as if they were defending a criminal case. But I do not want founders or angel investors to misunderstand what has changed. The valuation tax has gone. The need for a clean transaction, proper documentation, sensible pricing, and tax advice has not.

Why angel tax was such a bad tax

The name was always misleading. There is no separate “angel tax” sitting in the Income-tax Act. The phrase referred to Section 56(2)(viib), which treated certain excess amounts received by a closely held company for issuing shares as income from other sources.

Here is the basic problem.

Suppose I start a healthcare company. An angel investor agrees to invest ₹50 lakh for 5% of the company. The implied valuation is ₹10 crore. But a valuation officer, using a formula and the limited information available, decides that the fair market value is only ₹4 crore. The tax department could then treat the difference attributable to the issue price as taxable income in the hands of the company.

The company has not earned this money. It has received equity capital. It may have no revenue, no profits, and no predictable cash flow. Yet it could face a tax demand because an investor and founder negotiated a price that the department considered too high.

The government was trying to prevent unaccounted money from entering shell companies. Instead, it made genuine founders explain why an investor was willing to take a risk.

The original concern was not imaginary. A company could issue shares at an inflated price and use the transaction to bring undisclosed money into the formal system. But the cure was badly designed. It assumed that a young company had a discoverable “correct” value, when early-stage investing is precisely about making judgments under uncertainty.

A pre-revenue company does not have a market price in the way a listed company does. It has a founder, a product hypothesis, a small amount of evidence, perhaps a patent, perhaps a pilot, and an investor willing to accept a high probability of failure. The price is a negotiated expression of risk and hope. It is not a scientific constant waiting to be measured.

Angel tax abolished: what exactly has changed?

The important change is that the provision taxing the excess of the share issue price over fair market value has been removed. The announcement applies to all classes of investors, not merely foreign investors or a narrow category of recognised startups.

That distinction matters because the earlier relief was conditional and confusing. A startup generally had to satisfy several requirements, including recognition by the Department for Promotion of Industry and Internal Trade, limits relating to paid-up capital, valuation certification, and restrictions on the types of investors and assets involved.

In practice, founders often had to ask questions such as:

• Is the company recognised by DPIIT?
• Is the investor an eligible foreign investor, venture capital fund, or other permitted category?
• Does the company remain within the relevant capital threshold?
• Has a merchant banker issued the right valuation report?
• Will a future investment in another company or an asset create a problem?

These were not questions that helped a founder build a product or serve a customer. They were compliance traps. A founder could complete a legitimate funding round and still spend years wondering whether a future tax officer would regard the price as excessive.

The abolition should remove that particular source of tax exposure. It should also reduce the incentive for founders and investors to structure ordinary equity investments through unnecessarily complicated routes merely to avoid the provision.

But I would still ask every founder to read the fine print of the enacted law and the effective date with a tax professional. Budget speeches are policy announcements. The Finance Bill, enacted legislation, notifications, and departmental guidance determine how the change operates in practice. I would not assume that a press release answers every question about past transactions, pending assessments, or rounds signed before the effective date.

The first mistake: thinking the valuation no longer matters

This is where I expect some confusion.

Angel tax has gone. That does not mean that any valuation is sensible, safe, or useful.

A founder may now say, “I can raise at any price because the tax problem has disappeared.” I hope no founder does this. The tax department was never the only person who cared about valuation. Existing shareholders, future investors, employees holding options, and the company itself all care deeply.

If a founder raises ₹1 crore at a ₹20 crore valuation when the business is realistically worth ₹5 crore, the immediate tax issue may disappear. The commercial problem remains. The next investor may refuse to invest unless the company grows fourfold. If it cannot, the founder faces a down round, a complicated renegotiation, or a painful argument over liquidation preferences and control.

I have seen founders celebrate a high valuation as if it were revenue. It is not. A valuation is a price paid for a slice of a risky future. The higher the price, the greater the burden of proof imposed on the future.

In my own angel investing, I would rather invest at a fair price with a founder who understands the uncertainty than at an inflated price that makes everyone feel successful for six months. A low valuation is not necessarily good for an investor, and a high valuation is not necessarily good for a founder. The right price is the one that allows the company to raise enough money, gives the investor a reasonable chance of earning a return, and does not make the next round mathematically impossible.

How I would approach a funding round now

If I were advising a founder raising a seed round, I would keep the process practical. I would not begin with the question, “What is the maximum valuation I can get?” I would begin with the company’s cash needs and the evidence it expects to create.

1. Work out the next meaningful milestone. This might be a working product, a defined number of paying customers, regulatory approval, a clinical pilot, or a repeatable sales process. “We need money to grow” is not a milestone. “We need ₹1 crore to complete the product and reach ₹10 lakh of monthly recurring revenue” is at least a plan that can be examined.
2. Calculate the runway honestly. Include salaries, technology costs, professional fees, compliance, customer acquisition, and the founder’s own living expenses. Many early budgets quietly assume that founders will work without drawing a salary and that every vendor will wait patiently. Neither assumption survives contact with reality.
3. Decide how much dilution is acceptable. If the company needs ₹1 crore, the founder should understand what a 10%, 15%, or 20% sale means. The answer is not merely a percentage. It affects board rights, future fundraising, employee ownership, and the founder’s psychological relationship with the company.
4. Choose a valuation that can survive the next round. I would rather see a modest valuation supported by actual evidence than a heroic number based on a large theoretical market. The company should be able to grow into its price before it runs out of money.
5. Document the basis for the transaction. Even without Section 56(2)(viib), the company should preserve the cap table, board and shareholder approvals, investor correspondence, financial projections, valuation report where appropriate, and the final share subscription documents. Good records are not an admission that the valuation is weak. They are evidence that the transaction was real.

This is not a legal checklist. It is the order in which I think about the problem. Founders often reverse it. They start by asking a valuation consultant for a number, then try to fit the business plan around that number. That is like asking a doctor for a diagnosis before taking a history. The paperwork may look impressive, but the reasoning is backwards.

What angel investors should not do

I am pleased that the law no longer gives investors a reason to avoid ordinary Indian startups. But the abolition should not become an excuse for lazy investing.

An angel investor should still ask why the company is raising money, why the founder is raising this amount, what the money will achieve, and what evidence supports the proposed price. A valuation certificate cannot answer those questions. Neither can a famous investor in the round.

I would pay particular attention to three things.

First, the cap table. I have seen founders and investors focus on the headline valuation while overlooking convertible notes, advisory shares, employee options, side letters, and promises made informally to early supporters. A clean cap table is often more valuable than a clever term sheet.

Second, the rights attached to the shares. Two rounds at the same valuation can be economically very different if one includes liquidation preferences, anti-dilution protection, veto rights, guaranteed returns, or unusual redemption clauses. The number on the first page is not the whole deal.

Third, the source and purpose of the money. The abolition of Section 56(2)(viib) does not remove obligations under company law, securities regulations, anti-money-laundering rules, foreign exchange regulations, or tax provisions that apply to other parts of the transaction. If money comes from overseas, the Foreign Exchange Management Act and related rules still matter. If securities are issued improperly, the tax relief will not rescue the company.

This is why I remain wary when founders say, “The investor has agreed, so the legal work can be completed later.” In medicine, consent is not a substitute for a proper clinical record. In investing, enthusiasm is not a substitute for a properly executed transaction.

What happens to old investments and pending disputes?

This is the question I expect to occupy accountants and lawyers for some time.

The announcement clearly addresses the future of the provision, but founders with earlier funding rounds, notices, assessments, or appeals need advice specific to their facts. Was the round completed before or after the relevant effective date? Was a notice issued? Is the matter under assessment or appeal? Was the company eligible for an earlier exemption but unable to complete the required process? Has tax already been paid?

I would not offer a universal answer from a blog post. Tax law is full of dates, transitional provisions, and procedural details. A founder should collect the original subscription agreement, valuation report, board minutes, investor details, tax returns, notices, and correspondence before meeting an advisor. This will make the advice better and cheaper.

There is also a lesson here for investors who pressured founders to close quickly without completing the records. A funding round is not finished when money reaches the bank account. Shares must be issued correctly, statutory registers updated, filings made, and tax and regulatory positions recorded. The absence of angel tax does not make an undocumented issue respectable.

Will this bring back startup funding?

It will help. I do not believe it will solve the funding slowdown by itself.

Investors do not avoid a company only because of a tax provision. They avoid companies because the market may be too small, the product may not work, the founder may not be able to recruit, the customer acquisition cost may be too high, or the exit path may be unclear. Removing an administrative obstacle cannot turn a weak business into a strong one.

But removing a bad obstacle still matters. Early-stage investing already involves enough uncertainty. An investor may lose money because the founder makes poor decisions or because the market changes. The investor should not also have to worry that a genuine equity investment will be treated as an unexplained transfer of income because a valuation officer disagrees with the price.

The timing is also useful. Indian founders have found it harder to raise capital than they did during the exuberant funding period a few years ago. The Reuters report on the Budget announcement noted the decline in private equity and venture capital investment in the first half of 2024 compared with the previous year. I would not treat one tax change as a magic solution, but reducing friction when capital is already more selective is sensible policy.

Abolishing angel tax makes it easier to fund a startup. It does not make the startup worth more.

The wider lesson for Indian policy

I welcome the decision because it recognises something policymakers often forget: early-stage companies are not miniature listed companies.

A startup is a bundle of uncertain possibilities. Its value may depend on the founder’s ability to persuade a hospital chain, recruit a technical team, obtain a licence, or discover that customers will pay for a product. The evidence changes every few months. A valuation that looks unreasonable to an outsider may be rational to an investor who has spent ten hours with the founder, spoken to customers, and understood the technical advantage.

This does not mean every valuation is honest. It does not mean every angel is wise. It does not mean the government should stop looking for laundering and fraud. It means the state should target suspicious transactions rather than presume that a negotiated price above an artificial formula is itself evidence of wrongdoing.

There are better ways to identify shell companies: examine the identity and capacity of the investor, the movement of funds, the substance of the business, related-party transactions, and whether the company actually operates. A young company should not be presumed guilty merely because its future is difficult to price.

I see the same mistake in fertility treatment. A patient may ask for a single success percentage, as if the number can predict her individual outcome. I have to explain that age, ovarian reserve, sperm quality, embryo development, uterine factors, and previous treatment all matter. A single number gives the comfort of precision without the reality of understanding.

Early-stage valuation is similar. A formula can produce a number. It cannot replace judgment. The answer is not to abandon financial discipline, but to use judgment honestly and record the reasons behind it.

What founders should tell their teams and investors

I would explain the change in one sentence: the company should no longer face income tax merely because it issued shares to an investor at a price above the tax department’s assessment of fair market value, subject to the enacted law and effective date.

I would then add four cautions:

• The company still needs proper corporate approvals and filings.
• The valuation should still be commercially defensible.
• Foreign investment and securities regulations still apply where relevant.
• Existing disputes and earlier rounds need case-specific tax advice.

Founders who are raising their first round may find my earlier note on finding angel investors in India without warm introductions useful. The abolition of angel tax may increase investor interest, but it does not remove the need to approach the right investors with a clear, credible proposition.

I would also caution founders against spending the money they save on tax advice by hiring three different consultants to produce three different valuation reports. The purpose of professional advice is to improve the transaction, not to manufacture a thick file that nobody understands. One competent advisor who knows the company is better than a collection of certificates ordered after the fact.

The decision that matters most

For me, the most important change is psychological. Founders can now discuss a genuine funding round without carrying the fear that a future tax officer will retrospectively decide that an investor paid “too much.” That fear was corrosive. It made honest people behave defensively and encouraged complicated structures that obscured rather than clarified the investment.

But psychological relief can also produce overconfidence. The removal of one bad rule does not remove the discipline required to build a company. Investors will still lose money. Founders will still run out of runway. Customers will still refuse to pay. A high valuation will still create a high expectation.

I am happy that angel tax is gone. I am even happier when a founder I meet can explain, in plain language, how much money the company needs, what it will accomplish, and why the proposed price is fair to both sides. That conversation tells me far more than a valuation certificate ever did.

The government has finally stopped taxing the difference between a risky investment and a formula. Now founders and angels must make sure they do not replace that bad formula with an even worse fantasy.